Print

Emergent BioSolutions (EBS) Reports Financial Results for Third Quarter and First Nine Months of 2013  
11/8/2013 7:39:01 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Emergent BioSolutions Inc. (NYSE: EBS) announced today its financial results for the third quarter and nine months ended September 30, 2013.

Total revenues for Q3 2013 were $89.1 million as compared to $66.6 million in 2012. Total revenues for the first nine months of 2013 were $214.6 million as compared to $187.3 million in 2012. Net income for Q3 2013 was $13.5 million, or $0.37 per basic share, as compared to $6.6 million, or $0.18 per basic share, in 2012.

Help employers find you! Check out all the jobs and post your resume.

//-->